Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.86 - $8.01 $319,326 - $662,643
-82,727 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$7.01 - $10.94 $3,505 - $5,470
500 Added 0.61%
82,727 $627,000
Q4 2021

Feb 14, 2022

SELL
$9.55 - $14.29 $24,209 - $36,225
-2,535 Reduced 2.99%
82,227 $900,000
Q3 2021

Nov 15, 2021

BUY
$9.56 - $17.3 $810,324 - $1.47 Million
84,762 New
84,762 $1.1 Million

Others Institutions Holding TNGX

About Tango Therapeutics, Inc.


  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $359M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.